Acobiom 

Diagnostic Tests For Precision Medicine

OWNER

Philippe Outrebon (See Profile)


Sector

Diagnostics

Stage

Sales, licensing phases

Country

France

More than 60 scientific publications

Several patents on prognostic biomarkers/predictive biomolecular signature

Over 130,000 new pancreatic cancer cases treated annually in the US & the EU, representing a cost of $5Billions

This information is confidential, do not share or copy.

Under evaluation at least till: 24 April 2018.

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar